Posts by tag
oncology
Microbiota-Derived Bile Acids as Androgen Receptor Antagonists Enhance Anti-Tumour Immunity
The gut microbiota can transform cholesterol-derived bile acids into metabolites capable of blocking androgen receptors and strengthening anti-cancer immunity. The study, published in Cell, April 15, demonstrates how one of the microbiota-derived secondary bile acids is capable of suppressing tumour…
Is It Biology or Geography That Decides Who Survives Childhood Cancer?
Cancer is a word no parent ever wants to hear. But when that word comes with no access to treatment, it doesn’t just hurt—it destroys hope.A year ago, I was walking through a coastal town in Africa. It was a…
Zainab Shinkafi-Bagudu: What Africa’s First Lady of Cancer Will Bring to the Top Global Advocacy Role
Experience gained over decades of tackling cancer and supporting patients in Africa’s most populous country gives Zainab Shinkafi-Bagudu unique insights and influence to help bring about progress in similar settings across the globe. She talked to CancerWorld journalist, Diana Mwango,…
CancerWorld #104 (June 2025)
At CancerWorld, we don’t just publish science, we publish stories. As Alberto Costa, reminds us: CancerWorld is not about papers, it’s about people. The June, 2025 issue brings that philosophy into sharp focus. On our dual cover, we feature two…
(Re)Thinking Psycho-oncology in a world out of balance: What I learned after a year of interviews
"One must imagine Sisyphus happy" Albert Camus Why me? This is probably the present-day question of every patient with cancer! One of the consequences of our chaotic reality is cancer, which belongs to that class of diseases that impacts the…
CancerWorld issue #103 (May, 2025)
What does it take to change the odds in cancer care? Innovation? Yes. But also: persistence. Collaboration. The refusal to accept that some lives matter less because of where they’re born. In this issue of CancerWorld, we focus not just…
Adrian Gottschalk: Making a Difference for His Fellow Human Beings
I grew up around a lot of physicians,” begins Adrian Gottschalk, President and CEO of Foghorn Therapeutics, a biotech company redefining how we understand and treat complex diseases by targeting the chromatin regulatory system. “My late father was a professor…
“I really care about people.” – Philip Kantoff, A Life in Science and Medicine
“I wanted to be a scientist when I grew up.” Boston. The city where old bricks and new ideas stand side by side. Where science, education, and innovation breathe together. The wind cuts through the streets of New England, sharp…
What If the World’s Leading Prostate Cancer Epidemiologist Opened a Restaurant? A Conversation with Lorelei Mucci- A Harvard Scientist, A Mother, A Leader
I always close my interviews with a signature question: "Who should I speak with next?"It’s a small but revealing moment — a window into whom the giants of oncology admire, learn from, and find truly compelling. When I posed the…
CancerWorld #102 (April 2025)
The People Behind the Progress in Oncology is science. But it is also stories. It is policy. It is power. It is knowledge. It is culture. It is trust. And above all, it’s personal. This is the lens through which…